Literature DB >> 24976093

Treatment of ruptured vertebral artery dissecting aneurysms. A short report.

Osamu Hamasaki1, Fusao Ikawa2, Toshikazu Hidaka2, Yasuharu Kurokawa2, Ushio Yonezawa2.   

Abstract

We evaluated the outcomes of endovascular or surgical treatment of ruptured vertebral artery dissecting aneurysms (VADAs), and investigated the relations between treatment complications and the development and location of the posterior inferior cerebellar artery (PICA). We treated 14 patients (12 men, two women; mean age, 56.2 years) with ruptured VADAs between March 1999 and June 2012 at our hospital. Six and eight patients had Hunt and Hess grades 1-3 and 4-5, respectively. Twelve patients underwent internal endovascular trapping, one underwent proximal endovascular occlusion alone, and one underwent proximal endovascular occlusion in the acute stage and occipital artery (OA)-PICA anastomosis and surgical trapping in the chronic stage. The types of VADA based on their location relative to the ipsilateral PICA were distal, PICA-involved, and non-PICA in nine, two, and three patients, respectively. The types of PICA based on their development and location were bilateral anterior inferior cerebellar artery (AICA)-PICA, ipsilateral AICA-PICA, extradural, and intradural type in one, two, two, and nine patients, respectively. Two patients with high anatomical risk developed medullary infarction, but their midterm outcomes were better than in previous reports. The modified Rankin scale indicated grades 0-2, 3-5, and 6 in eight, three, and three patients, respectively. A good outcome is often obtained in the treatment of ruptured VADA using internal endovascular trapping, except in the PICA-involved type, even with high-grade subarachnoid hemorrhage. Treatment of the PICA-involved type is controversial. The anatomical location and development of PICA may be predicted by complications with postoperative medullary infarction.

Entities:  

Keywords:  dissecting aneurysm; internal endovascular trapping; medullary infarction; subarachnoid hemorrhage; vertebral artery

Mesh:

Year:  2014        PMID: 24976093      PMCID: PMC4178770          DOI: 10.15274/INR-2014-10024

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  21 in total

1.  Rebleeding from intracranial dissecting aneurysm in the vertebral artery.

Authors:  N Aoki; T Sakai
Journal:  Stroke       Date:  1990-11       Impact factor: 7.914

2.  Coil embolization for the treatment of ruptured dissecting vertebral aneurysms.

Authors:  A Kurata; T Ohmomo; Y Miyasaka; K Fujii; S Kan; T Kitahara
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

3.  Vertebral artery occlusion with vertebral artery-to-posterior inferior cerebellar artery stenting for preservation of the PICA in treating ruptured vertebral artery dissection.

Authors:  Joonho Chung; Bum-soo Kim; Dongwoo Lee; Tae-Hyun Kim; Yong Sam Shin
Journal:  Acta Neurochir (Wien)       Date:  2010-07-01       Impact factor: 2.216

4.  Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection.

Authors:  B M Kim; S H Kim; D I Kim; Y S Shin; S H Suh; D J Kim; S I Park; K Y Park; S S Ahn
Journal:  Neurology       Date:  2011-05-17       Impact factor: 9.910

5.  Stenting from the vertebral artery to the posterior inferior cerebellar artery.

Authors:  M J Kim; J Chung; S L Kim; H G Roh; B J Kwon; B-s Kim; T H Kim; B M Kim; Y S Shin
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

6.  Endovascular treatment of vertebral artery dissection using stents and coils: its pitfall and technical considerations.

Authors:  A Sadato; S Maeda; M Hayakawa; Y Kato; H Sano; Y Hirose; S Miyamoto; N Hashimoto
Journal:  Minim Invasive Neurosurg       Date:  2011-02-07

7.  Medullary infarction as a poor prognostic factor after internal coil trapping of a ruptured vertebral artery dissection.

Authors:  Hidenori Endo; Yasushi Matsumoto; Ryushi Kondo; Kenichi Sato; Miki Fujimura; Takashi Inoue; Hiroaki Shimizu; Akira Takahashi; Teiji Tominaga
Journal:  J Neurosurg       Date:  2012-10-05       Impact factor: 5.115

8.  Endovascular management of vertebrobasilar dissecting aneurysms.

Authors:  James D Rabinov; Frank R Hellinger; Pearse P Morris; Christopher S Ogilvy; Christopher M Putman
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

9.  Endovascular treatment of symptomatic intradural vertebral dissecting aneurysms.

Authors:  J P P Peluso; W J van Rooij; M Sluzewski; G N Beute; C B Majoie
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-10       Impact factor: 3.825

10.  Recurrent subarachnoid hemorrhage from untreated ruptured vertebrobasilar dissecting aneurysms.

Authors:  T Mizutani; T Aruga; T Kirino; Y Miki; I Saito; T Tsuchida
Journal:  Neurosurgery       Date:  1995-05       Impact factor: 4.654

View more
  4 in total

1.  The Silk Vista Baby: Initial experience and report of two cases.

Authors:  Pervinder Bhogal; Ken Wong; Christopher Uff; John Wadley; Hegoda Ld Makalanda
Journal:  Interv Neuroradiol       Date:  2019-03-31       Impact factor: 1.610

2.  Endovascular Treatment of Vertebral Artery Dissecting Aneurysms That Cause Subarachnoid Hemorrhage : Consideration of Therapeutic Approaches Relevant to the Angioarchitecture.

Authors:  Seung Hoon Lim; Hee Sup Shin; Seung Hwan Lee; Jun Seok Koh
Journal:  J Korean Neurosurg Soc       Date:  2015-09-30

Review 3.  Therapeutic Progress in Treating Vertebral Dissecting Aneurysms Involving the Posterior Inferior Cerebellar Artery.

Authors:  Lei Shi; Kan Xu; Xiaofeng Sun; Jinlu Yu
Journal:  Int J Med Sci       Date:  2016-06-30       Impact factor: 3.738

4.  Flow Alteration Therapy for Ruptured Vertebral Artery Dissecting Aneurysms Involving the Posterior Inferior Cerebellar Artery.

Authors:  Yasuhisa Kanematsu; Junichiro Satomi; Masaaki Korai; Toshiyuki Okazaki; Izumi Yamaguchi; Yoshiteru Tada; Masaaki Uno; Shinji Nagahiro; Yasushi Takagi
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-07-12       Impact factor: 1.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.